UNSPSC 51281516: Morinamide hydrochloride

This classification denotes an antitubercular agent C10H14N4O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2F6F46T9YC, chemically known as 2-pyrazinecarboxamide, n-(4-morpholinylmethyl)-, hydrochloride (1:1), but more generally known as morinamide hydrochloride, which bears US NIH Compound Identifier 164837. European Medicines Agency schedules Morinamide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03330MIG.

Most nations, for tariff and trade purposes, schedule morinamide hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, MORINAMIDE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1CNC(CN1)C(=O)NCN2CCOCC2.CL.

UNSPSC 51281516 Morinamide hydrochloride is a Commodity code that does not correspond to the work actually being solicited under it in recent state and local opportunities. The source record tags four pharmaceutical and medical supply procurements under this code, but none explicitly involve morinamide hydrochloride — a beta-blocker used in cardiology — as a line item or core deliverable. Seminole County, Florida's IFB60459723LAS solicits naloxone and drug deactivation systems for community health; the City of Tampa's 26P00145 requests medical and first aid supplies for its fire rescue division, including respiratory equipment, cardiac monitoring electrodes, and consumables; the Minnesota Multistate Cooperative Purchasing Alliance's S1070000015802 establishes contracts for generic multi-source pharmaceuticals and OTC products distributed across state and local facilities; and the Texas Health and Human Services Commission's HHS0017013 is an RFI exploring direct-to-manufacturer prescription programs. The code shows little relevant recent activity for the chemical substance it nominally describes.

Issuing bodies in the recent-opportunities block span county departments of health, municipal fire agencies, state cooperative purchasing alliances, and state health departments. The geographic spread includes Florida, Texas, Minnesota, and Oregon. Representative recent opportunities include Seminole County's competitive bid for naloxone and drug deactivation systems with a response deadline of July 26, 2023; the City of Tampa's sealed-bid solicitation for 169 line items of medical and first aid supplies with an estimated contract value of $700,000.00 and a deadline of March 13, 2026, designated as a sheltered-market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products due March 26, 2026, with contract effectiveness planned for July 1, 2026.